Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
24.38
+0.32 (1.33%)
At close: May 8, 2025, 4:00 PM
24.41
+0.03 (0.12%)
After-hours: May 8, 2025, 7:12 PM EDT
Moderna Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Moderna stock have an average target of 51.94, with a low estimate of 28 and a high estimate of 106. The average target predicts an increase of 113.04% from the current stock price of 24.38.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock from 20 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 11 | 13 | 14 | 14 | 14 | 14 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $78 → $70 | Strong Buy | Maintains | $78 → $70 | +187.12% | May 2, 2025 |
| Barclays | Barclays | Hold Maintains $45 → $40 | Hold | Maintains | $45 → $40 | +64.07% | May 2, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $32 → $28 | Hold | Maintains | $32 → $28 | +14.85% | May 2, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $50 → $32 | Hold | Maintains | $50 → $32 | +31.26% | May 2, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $39 → $32 | Hold | Maintains | $39 → $32 | +31.26% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
2.22B
from 3.24B
Decreased by -31.46%
Revenue Next Year
2.71B
from 2.22B
Increased by 22.14%
EPS This Year
-10.36
from -9.28
EPS Next Year
-7.89
from -10.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.0B | 5.6B | 8.4B | ||
| Avg | 2.2B | 2.7B | 3.3B | ||
| Low | 1.7B | 1.8B | 1.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -6.6% | 154.6% | 210.9% | ||
| Avg | -31.5% | 22.1% | 23.0% | ||
| Low | -48.6% | -17.3% | -37.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -8.69 | -2.16 | -4.55 | ||
| Avg | -10.36 | -7.89 | -6.57 | ||
| Low | -11.71 | -9.40 | -8.82 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.